Health advice for women with early-stage breast cancer could be improved through analysis of thousands of genetic samples, it has been revealed.
Nottingham University is undertaking a study which aims to collate thousands of samples into a single genetic resource.
Ian Ellis, professor of cancer pathology at the educational institution, explains that bringing together results from many patients could help to improve health advice for sufferers of the disease in the future.
This is due to the fact that common genetic changes during the early stages of the condition might be identified, he adds.
His development of the technique is being funded in part through a grant from the Breast Cancer Campaign.
Some £15,000 of funding has been allocated to the project by the action group in light of the perceived "research gap" relating to early breast cancer and genetics.
Meanwhile, the Radiological Society of North America has been examining the ways in which Doppler ultrasound may be used to detect breast cancer.
The organization explains that three-dimensional ultrasounds can be used by physicians to determine whether cancerous breast tissue is malignant or benign.
In order to do so, the rate of flow of blood to the tissue is analysed using Doppler imaging, with malignant cancerous cells known to frequently exhibit higher blood flow.